Clal Insurance’s Eloxx Pharmaceuticals, Inc. Common Stock ELOX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-13,526
| Closed | -$16K | – | 157 |
|
|
2023
Q4 | $16K | Hold |
13,526
| – | – | ﹤0.01% | 117 |
|
|
2023
Q3 | $65K | Sell |
13,526
-1,100
| -8% | -$6.16K | ﹤0.01% | 119 |
|
|
2023
Q2 | $57K | Hold |
14,626
| – | – | ﹤0.01% | 138 |
|
|
2023
Q1 | $37K | Hold |
14,626
| – | – | ﹤0.01% | 137 |
|
|
2022
Q4 | $27K | Buy |
14,626
+1
| +0% | +$5 | ﹤0.01% | 147 |
|
|
2022
Q3 | $99K | Hold |
14,625
| – | – | ﹤0.01% | 145 |
|
|
2022
Q2 | $158K | Hold |
14,625
| – | – | ﹤0.01% | 152 |
|
|
2022
Q1 | $328K | Hold |
14,625
| – | – | ﹤0.01% | 152 |
|
|
2021
Q4 | $413K | Hold |
14,625
| – | – | ﹤0.01% | 155 |
|
|
2021
Q3 | $954K | Hold |
14,625
| – | – | 0.01% | 152 |
|
|
2021
Q2 | $1.16M | Hold |
14,625
| – | – | 0.01% | 146 |
|
|
2021
Q1 | $1.94M | Hold |
14,625
| – | – | 0.02% | 134 |
|
|
2020
Q4 | $2.17M | Hold |
14,625
| – | – | 0.03% | 99 |
|
|
2020
Q3 | $1.54M | Hold |
14,625
| – | – | 0.03% | 97 |
|
|
2020
Q2 | $1.77M | Hold |
14,625
| – | – | 0.04% | 97 |
|
|
2020
Q1 | $1.15M | Buy |
14,625
+14,517
| +13,442% | +$2.36M | 0.03% | 91 |
|
|
2019
Q4 | $585K | Sell |
108
-14,517
| -99% | -$2.93M | 0.63% | 43 |
|
|
2019
Q3 | $2.64M | Sell |
14,625
-250
| -2% | -$71.1K | 0.06% | 81 |
|
|
2019
Q2 | $5.93M | Buy |
+14,875
| New | +$6.26M | 0.14% | 65 |
|